Sigrid Therapeutics successfully secured $4 million in an oversubscribed funding round. The investment, made by both existing and new investors, underlines the strong investor confidence in Sigrid's innovative SiPore® technology. Read Full Article
Deciphex, a trailblazer in digital pathology solutions, is delighted to announce a successful €10m venture debt financing round. This strategic investment will fuel the company's capacity growth, headcount increase, service enhancement, and expansion to new markets, addressing the growing global demand in pathology services. Read Full Article
Cinclus Pharma Holding AB (publ) ("Cinclus Pharma"), a pharma company focused on the development of a novel treatment for gastroesophageal reflux disease ("GERD"), today announces that two abstracts from the company's phase II study, LEED, on its leading drug candidate linaprazan glurate, developed for the treatment of moderate to severe erosive GERD ("eGERD"), are being presented at the leading gastro conference United European Gastroenterology ("UEG") which is held in Copenhagen 14 – 17 October 2023. Read Press Release here
Sigrid Therapeutics has started the Shine clinical trial for SiPore21, a device designed to control diabetes and obesity. SiPore technology is based on mesoporous silica particles (MSPs), a colloidal amorphous silicon dioxide matrix. It acts like a “molecular sieve” to physically prevent the interaction between digestive enzymes and food, thereby reducing food breakdown into basic absorbable units. The SiPore21 device, if cleared, will be registered as a Class IIb medical device. Read Full Article
Company will also create 25 jobs this year Health insurer VHI has launched a new telehealth dermatology service in partnership with AllView Healthcare, (formerly DermView) saying it will provide rapid access to care and treatment for skin conditions including acne, lesions and melanomas Read Full Article in the Irish Times
Company will also create 25 jobs this year Galway-based medtech company Bluedrop Medical has raised €10.5 million in a funding round that will help further the development of its remote patient monitoring system for the early detection of diabetic foot ulcers. Read Full Article in the Irish Times
Cork-based medical technologies company, AventaMed has been acquired by German firm, Karl Storz for an undisclosed amount. Originally spun out of Munster Technological University in 2015, the Cork firm developed a breakthrough single-use medical device, Solo+ TTD that addresses pain points of the current treatment of the surgical tympanostomy, a procedure that drains out the excess fluid built up in the ear. Read Full Article in the Examiner
Irish medtech company ProVerum has raised €30 million to support its clinical programme as it looks to go to market with its ground-breaking ProVee device in both Europe and the US. The series A funding round was co-led by Gilde Healthcare and Lightstone Ventures, with Atlantic Bridge and other existing investors also participating. ProVerum, which was founded by Ríona Ní Ghriallais and Conor Harkin in 2016 as a spinout from Trinity College Dublin, has developed a novel treatment solution for patients with symptomatic benign prostatic hyperplasia (BPH). This is a common condition where the prostate gland is enlarged, causing difficultly with urination and potentially kidney problems too. Read Full Article on the [...]
STOCKHOLM, Nov. 10, 2021 /PRNewswire/ -- Swedish healthtech startup Sigrid Therapeutics is set to prevent two of the world's biggest health challenges, type 2 diabetes and obesity with its SiPore15® powder. This vision has attracted a number of Sweden's family offices to invest just over $8.4 million in new capital making a total since inception of $17.5 million. "A quarter of the world population is affected with chronic lifestyle diseases which are preventable. That is why we created SiPore15® a patented silica-based powder clinically proven to lower long-term blood sugar and a range of metabolic parameters. Designed to act locally in the gut SiPore15® consists of precisely engineered micron-sized silica [...]
Angle investment into Irish start-ups is now higher than at pre-pandemic levels and thriving, according to figures from a business angels network. It says angels invested £7 million in fledgling businesses on the island of Ireland in the first half of this year, which was up 13 per cent when compared to the same pre-pandemic period in 2019. And the HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment, says that since its inception some £338 million has been pumped into start-ups through its network. HBAN, which is a joint initiative of Enterprise Ireland, [...]
